10x Genomics Cash on Hand 2018-2025 | TXG

10x Genomics cash on hand from 2018 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
10x Genomics Annual Cash on Hand
(Millions of US $)
2024 $393
2023 $389
2022 $433
2021 $588
2020 $680
2019 $424
2018 $65
2017 $0
10x Genomics Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $427
2024-12-31 $393
2024-09-30 $398
2024-06-30 $380
2024-03-31 $372
2023-12-31 $389
2023-09-30 $357
2023-06-30 $393
2023-03-31 $421
2022-12-31 $433
2022-09-30 $453
2022-06-30 $500
2022-03-31 $539
2021-12-31 $588
2021-09-30 $600
2021-06-30 $640
2021-03-31 $635
2020-12-31 $680
2020-09-30 $828
2020-06-30 $398
2020-03-31 $372
2019-12-31 $424
2019-09-30
2019-06-30
2019-03-31
2018-12-31 $65
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.523B $0.611B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.159B 58.73
Doximity (DOCS) United States $11.724B 54.28
Hims & Hers Health (HIMS) United States $11.606B 120.58
Tempus AI (TEM) United States $10.382B 0.00
IRhythm Technologies (IRTC) United States $4.374B 0.00
Inspire Medical Systems (INSP) United States $3.760B 58.76
Hinge Health (HNGE) United States $3.663B 0.00
Privia Health (PRVA) United States $2.509B 171.50
Enovis (ENOV) United States $1.745B 9.73
Phreesia (PHR) United States $1.609B 0.00
Schrodinger (SDGR) United States $1.559B 0.00
Clover Health Investments (CLOV) United States $1.537B 0.00
Azenta (AZTA) United States $1.469B 68.25
Evolent Health (EVH) United States $1.343B 114.40
Omnicell (OMCL) United States $1.301B 22.96
Claritev (CTEV) United States $0.725B 0.00
Fulgent Genetics (FLGT) United States $0.549B 0.00
Veradigm (MDRX) United States $0.499B 0.00
Standard BioTools (LAB) United States $0.471B 0.00
Butterfly Network (BFLY) United States $0.443B 0.00
Talkspace (TALK) United States $0.416B 124.25
TruBridge (TBRG) United States $0.326B 722.33
Outset Medical (OM) United States $0.321B 0.00
Nyxoah SA (NYXH) Belgium $0.271B 0.00
Health Catalyst (HCAT) United States $0.264B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.241B 0.00
CapsoVision (CV) United States $0.221B 0.00
Zepp Health (ZEPP) Netherlands $0.188B 0.00
KORU Medical Systems (KRMD) United States $0.144B 0.00
American Well (AMWL) United States $0.129B 0.00
EUDA Health Holdings (EUDA) Singapore $0.121B 0.00
Pulmonx (LUNG) United States $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.104B 0.00
CareCloud (CCLD) United States $0.102B 3.87
ImmunoPrecise Antibodies (IPA) Canada $0.088B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.081B 0.00
111 (YI) China $0.065B 0.00
P3 Health Partners (PIII) United States $0.047B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00